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Abstract 1 
Polychlorinated biphenyls (PCBs) are synthetic chemicals that bioaccumulate in the food chain. 2 
PCBs were used primarily for industrial applications due to their insulating and fire retardant properties, 3 
but were banned in the 1970s in the United States and in the 1980s in the United Kingdom, as adverse 4 
health effects following exposure were identified. Previous studies of populations with high PCB 5 
exposure have reported inverse associations with birth weight and gestational length. Birth weight is a 6 
powerful predictor of infant survival, and low birth weight can predispose infants to chronic conditions 7 
in adult life such as diabetes and cardiovascular diseases.  8 
Using data from the Avon Longitudinal Study of Parents and Children, we investigated the 9 
association between prenatal exposure to PCBs and fetal growth in a sample of 448 mother-daughter 10 
dyads. Concentrations of three common PCB analytes, PCB-118, PCB-153 and PCB-187, were measured 11 
in maternal serum collected during pregnancy, and fetal growth was measured by birth weight and birth 12 
length. Multivariable linear regression was used to examine the associations between PCB analytes and 13 
measures of fetal growth, after adjusting for parity, maternal age, pre-pregnancy BMI, educational 14 
status, tobacco use and gestational age of infant at sample collection. Birth length, ponderal index and 15 
gestational age were not associated with any of the PCB analytes. Mothers’ educational status modified 16 
associations for PCB analytes with birthweight. We observed significant inverse associations with birth 17 
weight only among daughters of mothers with less education. Daughter’s birth weight was 138.4g lower 18 
(95% CI: -218.0, —58.9) for each 10ng/g lipid increase in maternal serum PCB-118. Similarly, every 19 
10ng/g lipid increase in maternal serum PCB-153 was associated with a 41.9g (95% CI: -71.6, -12.2) 20 
lower birth weight. Every 10ng/g lipids increase in maternal serum PCB-187, was associated with a -21 
170.4g (95% CI: -306.1, -34.7) lower birth weight, among girls with mothers in the lowest education 22 
group. 23 
 3 
 
Our findings suggest that prenatal exposure to PCBs is inversely associated with daughters’ birth 24 
weight and that mothers’ education, which is a possible marker for socioeconomic status, significantly 25 
modified the association between maternal PCB concentrations and birth weight in female newborns.  26 
 27 
1. Introduction 28 
Polychlorinated biphenyls (PCBs) are a family of synthetic organic chemicals, comprising 209 29 
chemically related compounds that were used between 1930 and 1977 for various industrial 30 
applications because of their insulating and fire-retardant properties (1).  PCBs were banned in the 31 
1970s in the United States and in the 1980s in the United Kingdom, as adverse health effects following 32 
exposure were identified.  PCBs are biphenyls with between one and ten chlorine atoms attached, and 33 
the degree of chlorination determines the stability and lipophilicity of the specific PCB analyte (2). PCBs 34 
with lower degrees of chlorination tend to be more rapidly excreted from the body, while more 35 
chlorinated PCB compounds (e.g., PCB 153) are retained for a longer period of time, many with 36 
biological half-lives in the order of years (3, 4). There are no known natural sources of PCBs (5) and once 37 
PCBs are released into the environment, they do not readily break down and can easily cycle between 38 
air, water and soil.  Furthermore, they can be carried long distances and have been found in areas of 39 
snow and sea water far from the original release site (3).  40 
The most common sources of environmental exposure to these substances are dairy products, 41 
meat and especially fish (6). PCBs are stored mainly in human adipose tissue, and their poor metabolism 42 
results in elimination half-lives of approximately 10-15 years (7, 8). Animal and human studies have 43 
shown that PCBs cross the placenta (2) and the quantities of PCBs found in cord serum may be 44 
considerable relative to the size of the developing fetus (9). Endocrine pathways that are important for 45 
fetal development, such as thyroid hormone signaling, can be disrupted by PCBs, potentially leading to 46 
decreased in utero growth (5).  47 
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Birth weight is one of the most, if not the most, powerful predictors of infant survival (10), with 48 
low birth weight contributing to about 9.1 million infant deaths each year. Globally, 17% of total births 49 
are to low birth weight newborns (10). Low birth weight in early childhood can be associated with 50 
adiposity in adolescents and earlier pubertal maturation, and is a strong predictor of the development of 51 
obesity, hypertension and cardiovascular disease in adults (11). Additionally, low birth weight is a 52 
predictor for other adverse outcomes such as poor school performance, high blood pressure and 53 
cardiovascular diseases (12-15).  Therefore, it is important to determine whether prenatal PCB exposure 54 
is associated with birth outcomes such as low birth weight. The objective of this study was to investigate 55 
the association between prenatal exposure to PCBs and fetal growth in a well-characterized British 56 
sample of mother-daughter dyads. 57 
 58 
2. Methods 59 
2.1  Population 60 
The Avon Longitudinal Study of Parents and Children (ALSPAC) is a prospective birth-cohort 61 
study designed to evaluate the influences of genetic and environmental factors on health. During the 62 
years 1990–1992, 14,541 pregnant women residing in Avon, Great Britain with an estimated delivery 63 
date between April 1991 and December 1992 were enrolled in the study. These (initial) pregnancies 64 
resulted in a total of 14,062 live births and 13,988 children alive at one year of age.  An additional 713 65 
eligible children were enrolled at approximately 7 years of age and their data are available for analyses 66 
when including variables collected from the age of seven and later. Details of recruitment methods are 67 
described in detail elsewhere (16, 17).  68 
This study examined associations between maternal exposure to PCBs and fetal growth in girls 69 
in an ancillary study designed to look at the association between maternal serum concentrations of 70 
environmental exposures and daughter’s puberty characteristics (18). To be considered, girls had to 71 
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have at least two pubertal assessments to allow for classification of age at menarche. The ancillary study 72 
included all girls with early menarche (<11.5 years; n=218) and a random sample of girls without early 73 
menarche >11.5 years (n=230)). Informed consent was provided at the time of enrollment by the 74 
mothers. Human subjects’ protection and ethical approval were provided by the ALSPAC Law and Ethics 75 
Committee, the Local Research Ethics Committees, and the Centers for Disease Control and Prevention 76 
(CDC) Institutional Review Board. Please note that the study website contains details of all the data that 77 
are available through a fully searchable data dictionary, http://www.bris.ac.uk/alspac/researchers/data-78 
access/data-dictionary.  79 
2.2  Data Collection 80 
 Outcomes of interest included birth weight (in grams), birth length (in centimeters), and 81 
gestational age (in weeks) which were abstracted from medical records. Low birth weight was 82 
considered <2500 grams. Ponderal index was calculated using the following formula: (weight in 83 
grams/height in centimeters3) x 100 (19). Self-reported data on maternal prenatal characteristics and 84 
behaviors were obtained from questionnaires completed during pregnancy. Data collection and 85 
methods have been described in detail elsewhere (20).  86 
2.3  Laboratory Analyses 87 
 Blood samples were collected during pregnancy, processed and serum was stored frozen at -88 
20°C.  In 2008, samples were shipped to the National Center for Environmental Health’s Division of 89 
Laboratory Sciences, Centers for Disease Control and Prevention where PCB-118, PCB-153 and PCB-187 90 
were measured by gas chromatography isotope dilution high resolution mass spectrometry (GC-91 
IDHRMS) (21). This analysis presents lipid-adjusted exposures and measurements recorded as 0 ng/g are 92 
noted as <LOD.   93 
2.4  Statistical Analyses  94 
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  Pearson correlation coefficients were used to assess the relationship between PCB analytes. 95 
Stratum-weighted linear models, which accounted for the nested case-control study design, were used 96 
to estimate the association between individual PCB concentrations (PCB-118, PCB-153, and PCB-187) 97 
and fetal growth markers (birth weight, birth length, gestational age, and ponderal index). To adjust for 98 
the original selection criteria for the nested case-control study, cases (all girls who attained menarche 99 
<11.5 years) and controls (girls who attained menarche > 11.5 years) were assigned weights of 1 and 100 
15.1, respectively. Each PCB analyte was examined individually in a stratum-weighted model for each 101 
birth outcome, and backwards elimination was used to identify potential covariates which appreciably 102 
contributed to model fit or interpretation. .   Covariates considered included previous births (0/>1), 103 
maternal age (continuous), maternal race (white/non-white), pre-pregnancy BMI (continuous), 104 
educational status (categorical), tobacco use (binary), and gestational age when maternal serum sample 105 
was obtained (continuous).In this analysis, not attaining any General Certificates of Secondary Education 106 
(GCSEs, at 16 years of age) was coded as “< O”  (low) educational level, obtaining GCSEs as “O”  107 
(medium) and completing GCSEs and/or vocational training with additional education (e.g., University or 108 
Advanced) was considered “> O level” (high).  After backwards elimination, the remaining covariates for 109 
birth weight outcome included previous births, maternal BMI, race, education, tobacco use during 110 
pregnancy and gestational ages at sample collection.. For birth length, the confounders included in the 111 
model were parity and maternal BMI. The ponderal index model included the confounders, parity, 112 
maternal BMI, and tobacco use during pregnancy. For gestational age at birth, the only confounder 113 
remaining in the model was gestational age when serum sample was collected. Effect modification by 114 
maternal smoking and maternal education was also examined by testing appropriate interaction terms 115 
for statistical significance. SAS version 9.3 (SAS Institute Inc., Cary, NC) was used to conduct all analyses. 116 
All statistical tests were 2-tailed; a p-value of <0.05 was considered statistically significant.  117 
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 Ethical approval for the study was obtained from the ALSPAC Ethics and Law Committee and the 118 
Local Research Ethics Committees. The CDC Institutional Review Board also assessed and approved 119 
human subjects’ protection. Informed consent was provided by the mothers at the time of enrollment. 120 
 121 
3. Results 122 
More than half of the mothers were 29 years of age or younger at delivery and reported having 123 
normal pre-pregnancy BMI. About half of the mothers had an educational level of less than or equal to O 124 
level and most mothers were white (94%) (Table 1). The median gestational age at serum sample 125 
collection was 15 weeks with an interquartile range of 10–28 weeks. Among 448 daughters included in 126 
the study population, mean birth weight (± SD) was 3396.7 (± 498.7) g; birth length was 50.4 (±2.2)cm; 127 
ponderal index was 2.7 (± 0.2) kg/m3; and gestational age was 39.8 (±1.6) weeks (data not presented). 128 
Less than 4% of daughters were born preterm or weighed less than 2,500g.   129 
PCB analytes were detected in greater than 98% of the samples tested. PCB-153 had the highest 130 
median maternal serum concentrations followed by PCB-118 and PCB-187 (Table 1). Median (min-max) 131 
concentration in maternal samples of PCB-153 was 64.5 (3.7-200.1) ng/g; PCB-118 was 14.9 (<LOD-90.9) 132 
ng/g; and PCB-187 was 11.3 (<LOD-41.6) ng/g. Pearson correlation coefficients showed high levels of 133 
correlation between PCB-118 and PCB-153 (r= 0.80) and PCB-118 and PCB-187 (r = 0.73), and a very high 134 
level of correlation between PCB-153 and PCB-187 (r = 0.90).  135 
Birth length, ponderal index and gestational age were not associated with any of the PCB 136 
analytes in main effects’ models (Table 2). There was significant effect modification between maternal 137 
education and PCB analytes (PCB-118,  PCB-153, and PCB-187) for birth weight; therefore, results for 138 
birth weight were stratified by maternal education (Table 3). For all three analytes, we observed 139 
significant inverse associations with birth weight only among daughters of mothers with less than O-140 
level (low) education. Daughter’s birth weight was 138.4g lower (95% CI: -218.0, -58.9) for each 10ng/g 141 
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lipid increase in maternal serum PCB-118. Similarly, every 10ng/g lipids increase in maternal serum PCB-142 
153 was associated with a 41.9g (95% CI: -71.6, -12.2) lower birth weight. Every 10ng/g lipids increase in 143 
maternal serum PCB-187, was associated with a 170.4g (95% CI: -306.1,-34.7) lower birth weight (Table 144 
3), among girls with mothers in the lowest education group. 145 
 146 
4.  Discussion 147 
 In this analysis, we explored the associations between prenatal exposure to PCB-118, PCB-153 148 
and PCB-187 and fetal growth markers; birth weight, birth length, ponderal index, and gestational age.  149 
Our findings suggest that prenatal exposure to PCBs is inversely associated with birth weight and that 150 
mother’s education significantly modified the association between maternal PCB concentrations and 151 
birth weight in female newborns. Educational status may be a marker for socioeconomic status in this 152 
population; both education and socioeconomic status have positively associated with maternal diet 153 
quality and food security (22). This could in part contribute to the differences that we observed by 154 
mother’s education.    155 
Evidence from previous studies suggests prenatal exposure to PCBs has harmful effects on fetal 156 
growth (2, 23, 24). A meta-analysis of 12 European cohorts including 7,990 mother-child dyads and a 157 
pooled study of 9377 mother-child dyads from 11 European  cohorts (15 studies) both observed inverse 158 
associations between fetal PCB-153 exposure and birth weight  (25, 26). Compared to the maternal 159 
serum levels observed in other European studies, our median PCB-153 concentration (64.5 ng/g lipid), 160 
while not the lowest observed, does fall in the lower half of overall results (range of median PCB-153 161 
across European studies 15.3-394.4 ng/g lipid)(26) .  In contrast, Longnecker et al., in the U.S. 162 
Collaborative Perinatal Project of 1034 pregnant women enrolled between 1959-1965, found no 163 
associations between birth weight or gestational age and serum concentrations of 11 PCB analytes 164 
collected during the third trimester of pregnancy  (27).  Lignell et al., observed that breast milk 165 
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concentrations of PCB-138, PCB-153 and PCB-180 assessed within the first month post-delivery were 166 
positively associated with birth weight in a sample of first-time mothers in Sweden (n=411) (28) with 167 
stronger associations reported for males than females.  168 
Inconsistent findings across studies may be related to multiple factors such as differences in 169 
study design, population charcteristics, sample sizes, timing or type of sample measured, and overall 170 
distribution of exposure (e.g., low v. high). PCB levels measured in breast milk collected after birth may 171 
not be representative of in utero exposure. Also, differences in the PCB analytes examined can lead to 172 
varied findings since PCB analytes vary in their ability to bioaccumulate and in level of toxicity (27, 29). 173 
PCBs with lower degrees of chlorination tend to be more rapidly excreted from the body; thus, may be 174 
poorer biomarkers of long-term exposure.  175 
Although the possible mechanism of PCBs on birth weight is not known, it could be related to 176 
the endocrine-disrupting properties of PCBs (30). Estrogens promote fetal growth and PCBs have been 177 
found to have both estrogenic and anti-estrogenic roles (31). In animal models, a growing body of 178 
literature suggests that exposure to endocrine-disrupting chemicals can have a wide range of effects on 179 
metabolism such altering insulin metabolism and disrupting energy balance (1, 32).  For example, 180 
PCB153 concentrations have been inversely associated with serum thyroxine levels in an animal model 181 
(33).   182 
 Our analysis was conducted on a sample of mothers and their daughters chosen from a nested 183 
case-control study for pubertal development. Although our results could be biased if the girls excluded 184 
from the analysis were different from girls who were included in the analysis, it is unlikely since mean 185 
values of maternal characteristics and fetal growth outcomes for the study sample are similar to those 186 
of the group of girls enrolled in the full cohort (19). These analyses were performed on a sample of girls 187 
because data on prenatal exposure to PCBs are not currently available for ALSPAC boys.  It is unknown 188 
whether these results can be extrapolated to males.  Additionally, PCB measurements are only available 189 
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for a single time point during pregnancy and daughters’ PCB concentrations measured at birth are not 190 
available. The timing of specimen collection is important and in our analyses we controlled for 191 
gestational age at sample collection, because evidence suggests that concentrations decline from 192 
preconception to postnatally sensitive windows (34). Further analyses will explore the association 193 
between prenatal PCB exposure and postnatal growth in girls at other time points.  Lastly, there is the 194 
possibility of residual confounding by unmeasured or poorly measured (e.g., maternal smoking) 195 
covariates.   196 
 197 
5. Conclusions  198 
Our results are consistent with results from other studies that show an association between 199 
higher prenatal PCB levels and lower birth weight (23, 25, 35). Birth weight is reflective of fetal 200 
development from conception to birth, and low birth weight is associated with negative health 201 
outcomes later in life. Pre-term or low birth weight infants are at a heightened risk for morbidities and 202 
chronic conditions, including cardiovascular diseases and adverse behavioral, cognitive and psychiatric 203 
outcomes (36). In our study, mother’s education, a possible marker for socioeconomic status, 204 
significantly modified the association between maternal PCB concentrations and birth weight in female 205 
newborns. We observed significant inverse associations with birth weight only among daughters of 206 
mothers with less education (lower socioeconomic status). This relationship has not previously been 207 
identified and should be investigated in future research.  208 
209 
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Table 1: Frequency distribution and lipid adjusted maternal serum concentrations (ng/g lipid) of selected 210 
polychlorinated biphenyl (PCB) analytes in a sample of British girls (n=448). 211 
 Frequency 
n (%) 
PCB118 
Median (min-
max) 
PCB153 
Median (min-max) 
PCB187 
Median (min-
max) 
Overall 448 (100) 14.9 (<LODa-90.9) 64.50 (3.70-200.10) 11.3 (<LOD-41.6) 
Maternal pre-pregnancy BMI 
Underweight 18 (4.0) 14.2 (5.2-28.1) 79.7 (45.5-120.8) 14.0 (8.9-23.1) 
Normal 290 (64.7) 15.2 (<LOD-52.4) 68.6 (3.7-184.7) 11.7 (<LOD-34.4) 
Overweight  63 (14.1) 14.8 (5.7-58.6) 57.2 (25.1-152.9) 9.6 (<LOD-25.60) 
Obese 31 (6.9) 18.1 (6.1-90.9) 57.3 (25.9-200.1) 9.6 (<LOD-41.60) 
Missing  46 (10.3)  13.0(4.2-29.4) 58.7 (24.0-153.40) 10.4 (3.7-23.90) 
Maternal age at delivery (years) 
<25 92 (20.5) 10.4 (4.2-34.20) 44.2 (22.10-141.10) 7.8 (<LOD-21.0) 
25-29  164 (36.6) 14.5 (5.2-58.6) 59.8 (26.3-184.7) 10.3 (<LOD-34.4)  
≥30  189 (42.2) 18.6 (<LOD-90.90) 81.9 (3.70-200.10) 14.5 (<LOD-41.6)  
Missing  3 (0.7) 14.2 (10.9-19.2) 80.4 (63.4-94.0) 13.6 (11.2-23.1) 
Maternal educationb 
< O level (low) 89 (19.9) 13.3 (2.0-90.9) 57.3 (3.7-200.1) 10.5 (<LOD-41.6)  
O level (medium) 140 (31.3) 13.3 (5.20-37.40) 55.9 (25.9-154.9) 9.6 (<LOD-28.1)  
> O level (high)  200 (44.6) 18.1 (<LOD-52.4) 74.4 (11.8-184.7) 13.0 (<LOD-34.4)  
Missing 19 (4.2) 12.8(5.2-35.2) 62.9 (32.60-163.90) 11.6 (5.5-32.5)  
Maternal race  
White 423 (94.4) 14.9 (<LOD-90.90) 64.8 (3.70-200.10) 11.2 (<LOD-41.6)  
Nonwhite 8 (1.8) 19.5 (2.8-35.3) 67.7 (11.80-140.10) 14.8 (3.7-24.2)  
Missing 17 (3.8) 12.5 (5.2-35.2) 58.5 (32.60-125.90) 10.3 (5.5-23.10)  
Previous births  
0  208 (46.4) 15.5 (4.2-41.40) 63.9 (22.10-184.70) 10.9 (<LOD-34.4)  
≥ 1 211 (47.1) 14.9 (<LOD-90.9) 66.9 (3.7-200.1) 11.9 (<LOD-41.6)  
Missing 29 (6.5) 11.7 (5.2-35.2)  59.7 (28.1-110.4) 11.2 (5.2-24.0)  
Tobacco use during first 3 months 
Yes 102 (22.8) 13.0 (4.2-51.0) 60.8 (24.0-153.4) 10.5 (4.6-29.0)  
No 328 (73.2) 16.5 (<LOD-90.90) 67.8 (3.7-200.10) 11.6 (<LOD-41.60)  
Missing 18 (4.0) 10.9 (5.2-21.3) 59.7 (28.1-94.0)  10.5 (5.2-23.1)  
Low birth weight (<2500 g)  
Yes  17 (3.8) 20.7 (5.9-90.9) 74.4 (26.9-200.1) 13.0 (4.9-41.6)  
No  423 (92.4) 14.7 (<LOD-58.6) 63.7 (3.7-184.7) 10.9 (<LOD-34.4)  
Missing 8 (1.8) 15.3 (10.90-27.30) 75.5 (59.3-130.8) 13.9 (10.5-23.1)  
Preterm delivery (<37 weeks) 
Yes  14 (3.1) 16.7 (7.6-35.2) 69.7 (37.8-125.9) 12.0 (6.6-27.0) 
No  431 (96.2) 14.8 (<LOD-90.9) 63.6 (3.7-200.10) 11.2 (<LOD-41.6)  
Missing 3 (0.7) 14.2 (10.9-19.2) 80.4 (63.4-94.0)  13.6 (11.2-23.1)  
Menarche (years) 
< 11.5 218 (51.3) 15.2 (2.0-58.6) 62.1 (3.7-163.9)  10.9 (<LOD-32.5)  
> 11.5  230 (48.7)  14.8 (<LOD-90.9)  68.2 (22.1-200.1)  11.5 (<LOD-41.6)  
a <LOD= Below limit of detection 212 
b O–level of education is the qualification obtained at 16 years of age when obligatory schooling ends.  213 
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 216 
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 219 
 220 
Table 2. Adjusted Regression coefficients (β)a for associations between prenatal growth measuresb and maternal serum concentrations of PCB-221 
118, PCB-153, and PCB-187 in a sample of British girls. 222 
 PCB-118 p-value PCB-153 p-value PCB-187 p-value 
Birth length c(cm) (n=363)       
Unadjusted β (95% CI) 0.12 (-0.16, 0.41) 0.39 -0.04 (-0.12, 0.04) 0.30 -0.34 (-0.72, 0.05) 0.09 
Multivariate β (95% CI) 0.08 (-0.21, 0.36) 0.60 -0.04  (-0.12, 0.04) 0.29 -0.33 (-0.73, 0.06) 0.10 
Ponderal Index d(n=357)       
Unadjusted β (95% CI) -0.03 (-0.06, 0.01) 0.10 -0.01 (-0.01, 0.00) 0.24 -0.02 (-0.07, 0.02) 0.30 
Multivariate β (95% CI) -0.03  (-0.06, 0.01) 0.10 0.00 (-0.01, 0.01) 0.97 0.00  (-0.04, 0.05) 0.91 
Gestational agee (wks) (n=444)      
Unadjusted β (95% CI) 0.02 (-0.15, 0.18) 0.85 -0.01 (-0.06, 0.04) 0.72 -0.12 (-0.37, 0.13) 0.35 
Multivariate β (95% CI) 0.02 (-0.15, 0.18) 0.82 -0.01 (-0.06, 0.04) 0.80 -0.11 (-0.36, 0.14) 0.38 
a per 10 unit (ng/g lipid) increase in analyte. In multivariate models maternal pre-pregnancy BMI, and gestational age at maternal sample 223 
collection  were entered as continuous variables (rather than categorical as presented in table 1). 224 
b.  For birthweight, significant interactions were observed with educational status; thus, final stratified results for birthweight are provided in 225 
Table 3.  226 
c Adjusted for sampling design, previous births and maternal pre-pregnancy BMI 227 
dAdjusted for sampling design, previous births, maternal pre-pregnancy BMI, maternal tobacco use during pregnancy 228 
e Adjusted for sampling design, gestational age at maternal s sample collection 229 
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 230 
Table 3. Regression coefficients (β)ab for birth weight (g) and maternal serum concentration of PCB-118 , 231 
PCB-153, PCB-187 stratified by maternal education level (low, medium, high) in a sample of British girls 232 
 PCB-118  PCB-153  PCB-187  
Education 
level 
β (95% CI) p- 
value 
β (95% CI) p- 
value 
β (95% CI) p- 
value 
< O level (low)      
(n=89) -138.43 
(-218.0,-58.9) 
0.0009 -41.90 
(-71.63, -12.17) 
0.0006 -170.40 
(-306.10, -34.70) 
0.01 
O level (medium)      
(n=140) -7.92 
(118.3, 102.5) 
0.89 0.51 
(-30.77, 31.78) 
0.97 8.30  
(-151.16, 167.76) 
0.92 
   > O level (high) 
(n=200) -24.51 
(--56.1, 105.1) 
0.55 -2.43 
(-24.38, 19.52) 
0.83 -8.30 
(-114.60, 97.99) 
0.88 
a per 10 unit (ng/g lipid) increase in analyte. In multivariate models maternal pre-pregnancy BMI, and 233 
gestational age at sample collection age were entered as continuous variables (rather than categorical as 234 
presented in table 1). P-interactions = 0.02 (PCB-118); 0.02 (PCB-153); 0.03 (PCB-187) 235 
b adjusted for sampling design, previous births, maternal pre-pregnancy BMI, maternal tobacco use during 236 
pregnancy, gestational age at sample collection and maternal race ) 237 
 238 
 239 
  240 
  241 
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